Guardant Health, Inc.
GH
$48.30
$0.891.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.98% | -18.52% | 3.44% | 30.68% | 26.76% |
| Total Depreciation and Amortization | -1.15% | 1.47% | 5.59% | 10.59% | 19.24% |
| Total Amortization of Deferred Charges | 0.23% | 0.19% | 0.23% | 0.19% | 0.23% |
| Total Other Non-Cash Items | 284.95% | 319.15% | 70.17% | -61.92% | -77.48% |
| Change in Net Operating Assets | -213.04% | 392.54% | -72.92% | 46.92% | -12.55% |
| Cash from Operations | 26.19% | 24.61% | 16.77% | 20.96% | -5.01% |
| Capital Expenditure | -71.26% | 23.18% | 59.66% | 68.06% | 73.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -126.28% | 50.42% | 1,209.08% | 182.76% | 278.72% |
| Cash from Investing | -131.10% | 58.28% | 3,282.89% | 262.37% | 460.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.05% | -74.83% | -74.83% | 4,423.85% | 4,118.03% |
| Repurchase of Common Stock | -40.05% | -13.43% | -0.59% | -48.45% | -42.13% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.99% | 94.88% | 116.42% | 92.32% | 92.18% |
| Cash from Financing | -100.21% | -76.23% | -72.90% | 351.22% | 352.46% |
| Foreign Exchange rate Adjustments | -94.29% | 219.23% | -82.96% | -94.23% | 43.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -150.81% | -22.68% | 1,268.43% | 358.76% | 383.08% |